Therapeutic potential for P2Y2 receptor antagonism

KJ Jasmer, K Muñoz Forti, LT Woods, S Cha… - Purinergic …, 2023 - Springer
G protein-coupled receptors are the target of more than 30% of all FDA-approved drug
therapies. Though the purinergic P2 receptors have been an attractive target for therapeutic …

P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment

FB Morrone, P Vargas, L Rockenbach, TB Scheffel - Molecules, 2021 - mdpi.com
Gliomas are the most common malignant brain tumors in adults, characterized by a high
proliferation and invasion. The tumor microenvironment is rich in growth-promoting signals …

Purinergic P2Y2 and P2X4 receptors are involved in the epithelial-mesenchymal transition and metastatic potential of gastric cancer derived cell lines

M Reyna-Jeldes, E De la Fuente-Ortega, D Cerda… - Pharmaceutics, 2021 - mdpi.com
Gastric cancer (GC) is a major health concern worldwide, presenting a complex
pathophysiology that has hindered many therapeutic efforts so far. In this context, purinergic …

Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer

CFF Gardani, EL Pedrazza, VS Paz, GG Zanirati… - Pharmaceuticals, 2023 - mdpi.com
Prostate cancer (PC) is the most diagnosed tumor in males and ranks as the second leading
cause of male mortality in the western world. The CD39 and CD73 enzymes play a crucial …

MTHFD1L confers a poor prognosis and malignant phenotype in esophageal squamous cell carcinoma by activating the ERK5 signaling pathway

J Zhou, Y Yang, J Cheng, S Luan, X Xiao, X Li… - Experimental Cell …, 2023 - Elsevier
MTHFD1L, a key enzyme of folate metabolism, is seldom reported in cancer. In this study,
we investigate the role of MTHFD1L in the tumorigenicity of esophageal squamous cell …

Blockade of the P2Y2 receptor attenuates alcoholic liver inflammation by targeting the EGFR-ERK1/2 signaling pathway

ZN Liu, QQ Su, YH Wang, X Wu… - Drug Design, Development …, 2022 - Taylor & Francis
Purpose It is well known that inflammation plays a key role in complex pathological
progressions of alcohol-associated liver disease (ALD). To date, effective therapy for ALD is …

[HTML][HTML] Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer

C Liu, X Wang, S Wang, J Xiang, H Xie, Z Tan, X Li… - Translational …, 2023 - Elsevier
Background P2Y receptors are a family of G protein-coupled receptor genes that have an
important function in cancer development and metastasis. However, systematic studies have …

P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells

P Vargas, TB Scheffel, FM Diz, L Rockenbach… - Purinergic …, 2022 - Springer
Glioblastoma (GBM) is the most aggressive and lethal among the primary brain tumors, with
a low survival rate and resistance to radio and chemotherapy. The P2Y12 is an adenosine …

Identification and validation of common reference genes for normalization of esophageal squamous cell carcinoma gene expression profiles

J Xu, M Yang, A Shao, H Pan, Y Fan… - BioMed Research …, 2022 - Wiley Online Library
Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer
with Chinese characteristics, and its five‐year survival rate is less than 20%. Early diagnosis …

CD39 activities in the treated acupoints contributed to the analgesic mechanism of acupuncture on arthritis rats

YJ Li, J Lin, SQ Tang, WM Zuo, GH Ding, XY Shen… - Purinergic …, 2024 - Springer
Our previous work had identified that at the acupuncture point (acupoint), acupuncture-
induced ATP release was a pivotal event in the initiation of analgesia. We aimed to further …